Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients (HEPAVAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00190242
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : December 16, 2011
Ensemble contre le SIDA
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2006
  Actual Study Completion Date : October 2009